Skip to main content

Table 3 GBS serotype counts in Swedish invasive and commensal isolates

From: Virulence, phenotype and genotype characteristics of invasive group B Streptococcus isolates obtained from Swedish pregnant women and neonates

Sero-type

EOD (N = 155)

LOD (N = 51)

Maternal (N = 19)

Stillbirth (N = 4)

Total GBS Invasive Isolates (N = 229)

Swedish GBS Commensal Isolates (N = 356)

p-value, total invasive vs. commensal

Ia

30 (19.4%)

4 (7.8%)

1 (5.3%)

1 (25%)

36 (15.7%)

39 (11%)

0.1

Ib

8 (5.2%)

1 (2.0%)

5 (26.3%)

 

14 (6.1%)

46 (13%)

0.008

II

8 (5.2%)

1 (2.0%)

1 (5.3%)

1 (25%)

11 (4.8%)

57 (16%)

 < 0.001

III

78 (50.3%)

36 (70.6%)

3 (15.8%)

 

117 (51.1%)

85 (24%)

 < 0.001

IV

3 (1.9%)

2 (3.9%)

2 (10.5%)

 

7 (3.1%)

53 (15%)

 < 0.001

V

25 (16.1%)

5 (9.8%)

7 (36.8%)

2 (50%)

39 (17.0%)

68 (19%)

0.58

VII

1 (0.6%)

   

1 (0.4%)

2 (0.5%)

1

VIII

 

1 (2.0%)

  

1 (0.4%)

4 (1%)

0.65

IX

1 (0.6%)

1 (2.0%)

  

2 (0.9%)

0 (0%)

0.15

NT

1 (0.6%)

   

1 (0.4%)

2 (0.8%)

 
  1. This table presents a comparison of serotypes between Swedish GBS invasive and commensal isolates. The percent of serotypes in Swedish commensal GBS isolates (collected in 2005) was previously published and is presented here for comparison with the Swedish invasive GBS isolates [36]. The N in each serotype group of the Swedish commensal GBS isolates was estimated from the reported percent. In addition, serotyping of a subset of the invasive GBS isolates was previously published [8]. Fisher’s exact test was performed to compare the proportion of serotypes within the invasive and commensal GBS isolates of each serotype group (Groups Ia, Ib, II, III, IV and V) with multiple hypothesis correction for 6 tests. Serotype VI was not observed in these isolates
  2. EOD Early-onset disease; LOD Late-onset disease; NR Not reported. NT Non-typeable